FIGO regularly issues statements and joint statements.
We are delighted to announce early bird registration for FIGO Cape Town 2025 is now open! Our world-class Congress will take ...
"The results present that FIGO AUB System 2 (PALM-COEIN) is widely recognised globally, but many trainees lack formal ...
A new special article published in the International Journal of Gynecology & Obstetrics (IJGO) presents findings from a comprehensive global survey of FIGO's… ...
In 2022, the World Health Organization (WHO) updated its Abortion care guideline, widening its scope to include evidence-based recommendations in legal, regulatory, policy and service-delivery aspects ...
A groundbreaking standardised protocol for managing complex caesarean sections has been introduced by the FIGO Committee on Childbirth and Postpartum Haemorrhage. Published in the International ...
Project leads: Professor Sean Kehoe, Past Chair and current member of the FIGO Committee on Women's Cancer; Professor Joanna Cain, Past Chair and current member of WHO Guidelines Development Group ...
Postpartum Haemorrhage (PPH) is the leading cause of maternal mortality in low-income countries. The most common cause of PPH is poor contraction of the uterus (uterine atony). Primary PPH is often ...
The Committee on Women at Menopausal Age employs evidence-based strategies for comprehensive analysis of the root causes of health challenges specific to older women. By implementing research-driven ...
This website is owned and operated by The International Federation of Gynecology and Obstetrics, a company limited by guarantee registered in England Wales under company number 05498067 of 3 Waterloo ...
FIGO is on a mission as the global voice of women's health, to improve women and girls’ health and wellbeing, reduce disparities in health care and advance the practice of obstetrics and gynaecology ...